Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Creative Medical Technology Holdings, Inc. (CELZ)

0.6523   0.02 (3.11%) 06-26 22:00
Open: 0.65 Pre. Close: 0.6326
High: 0.69 Low: 0.639
Volume: 1,084,651 Market Cap: 6(M)
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.69 - 0.69 0.69 - 0.7
Low: 0.63 - 0.63 0.63 - 0.64
Close: 0.65 - 0.65 0.65 - 0.66

Technical analysis

as of: 2022-06-24 4:38:45 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 1.04     One year: 1.26
Support: Support1: 0.6    Support2: 0.49
Resistance: Resistance1: 0.89    Resistance2: 1.08
Pivot: 0.73
Moving Average: MA(5): 0.63     MA(20): 0.78
MA(100): 1.79     MA(250): 5.57
MACD: MACD(12,26): -0.3     Signal(9): -0.3
Stochastic oscillator: %K(14,3): 8.8     %D(3): 7.7
RSI: RSI(14): 25.1
52-week: High: 20  Low: 0.6
Average Vol(K): 3-Month: 736 (K)  10-Days: 1,285 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ CELZ ] has closed above bottom band by 31.3%. Bollinger Bands are 66.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 13 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 23 Jun 2022
Thinking about buying stock in -

Wed, 15 Jun 2022
Creative Medical Technology Holdings Announces Agreement with Greenstone Biosciences, Inc. for Development of a Next Generation iPSC Pipeline for its ImmCelz® Immunotherapy Platform - Yahoo Finance

Wed, 15 Jun 2022
Creative Medical Technology Holdings (CELZ) Stock Price: Why It Increased 1.43% Today - Pulse 2.0

Fri, 03 Jun 2022
Stock Analysts' Upgrades for June 3rd (BFRI, BIRD, BIVI, BVNRY, BYDDY, CATC, CDTX, CELZ, CEVA, CFFN) - Defense World

Sun, 29 May 2022
Wall Street Breakfast: The Week Ahead - Seeking Alpha

Thu, 14 Apr 2022
Should You Sell Creative Medical Technology Holdings Inc (CELZ) in Biotechnology Industry? - InvestorsObserver

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. -38 (M)
Shares Float 0 (M)
% Held by Insiders 6.33e+006 (%)
% Held by Institutions 5.77e+006 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS 39800
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -7.68
Profit Margin (%) 21
Operating Margin (%) 892.7
Return on Assets (ttm) -3
Return on Equity (ttm) 562.1
Qtrly Rev. Growth 0
Gross Profit (p.s.) -17.94
Sales Per Share 0
EBITDA (p.s.) 23484.5
Qtrly Earnings Growth -3.03e+006
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio 0
PEG Ratio 0
Price to Book value -0.09
Price to Sales 0
Price to Cash Flow 0

Stock Dividends

Dividend 292060
Forward Dividend 801450
Dividend Yield 44773900%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.